Literature DB >> 16305883

Borderzone geometry after acute myocardial infarction: a three-dimensional contrast enhanced echocardiographic study.

Benjamin M Jackson1, Landi M Parish, Joseph H Gorman, Yoshiharu Enomoto, Hiroaki Sakamoto, Theodore Plappert, Martin G St John Sutton, Ivan Salgo, Robert C Gorman.   

Abstract

BACKGROUND: Regional myocardial geometry, function, and perfusion status are critical variables for understanding infarction-induced left ventricle (LV) remodeling. Three-dimensional contrast echocardiography (3DCE) is uniquely suited to measure these parameters. We evaluate the ability of 3DCE to assess geometric changes in the normally perfused but hypocontractile borderzone myocardium (BZM) immediately after a myocardial infarction (MI) in an ovine model, and we compare 3DCE with two-dimensional contrast echocardiography (2DCE) in the long and short axis.
METHODS: Four sheep were studied with 3DCE and 4 were studied using 2DCE, before and 30 minutes after an anteroapical MI. Each 3DCE data set was acquired over 18 consecutive cardiac cycles. The LV geometry was reconstructed and perfusion data spatially correlated, thereby constituting a 3D model of ventricular geometry and perfusion. The borderzone was defined as the contrast-perfused myocardium adjacent to the infarct.
RESULTS: The 2DCE short-axis analysis demonstrated decreased curvature and decreased wall thickness in the borderzone after MI. These findings are consistent with increased BZM wall stress. However, the long-axis 2DCE analysis demonstrated increased BZM wall thickness and a surprising change in BZM concavity acutely after infarction. The 3DCE analysis confirmed these findings and added additional information regarding regional variability in BZM geometry that was not evident in the two orthogonal 2D views.
CONCLUSIONS: This study provides evidence that regional changes in BZM geometry are more complex than previously believed and are not necessarily indicative of increased regional stress. The superiority of 3DCE over 2DCE for assessing these changes is strongly supported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305883     DOI: 10.1016/j.athoracsur.2005.05.103

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Regional myocardial contractile function: multiparametric strain mapping.

Authors:  Brian P Cupps; Ajay K Taggar; Lina M Reynolds; Jennifer S Lawton; Michael K Pasque
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-03-16

2.  Temporal changes of strain parameters in the progress of chronic ischemia: with comparison to transmural infarction.

Authors:  Kiyotake Ishikawa; Yoshiaki Kawase; Dennis Ladage; Elie R Chemaly; Lisa Tilemann; Kenneth Fish; Javier Sanz; Mario J Garcia; Roger J Hajjar
Journal:  Int J Cardiovasc Imaging       Date:  2012-01-10       Impact factor: 2.357

3.  Mechanisms of Post-Infarct Left Ventricular Remodeling.

Authors:  Brent A French; Christopher M Kramer
Journal:  Drug Discov Today Dis Mech       Date:  2007

4.  Left ventricular regional wall curvedness and wall stress in patients with ischemic dilated cardiomyopathy.

Authors:  Liang Zhong; Yi Su; Si-Yong Yeo; Ru-San Tan; Dhanjoo N Ghista; Ghassan Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-02       Impact factor: 4.733

5.  Assessment of regional left ventricular myocardial function in rats after acute occlusion of left anterior descending artery by two-dimensional speckle tracking imaging.

Authors:  Qian Fu; Mingxing Xie; Jing Wang; Xinfang Wang; Qing Lv; Xiaofang Lu; Lingyun Fang; Long Chang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

6.  Myocardial dysfunction in the periinfarct and remote regions following anterior infarction in rats quantified by 2D radial strain echocardiography: an observational cohort study.

Authors:  Raymond Q Migrino; Xiaoguang Zhu; Mineshkumar Morker; Tejas Brahmbhatt; Megan Bright; Ming Zhao
Journal:  Cardiovasc Ultrasound       Date:  2008-04-29       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.